Initiation, continuation, or withdrawal of angiotensin‐converting enzyme inhibitors/angiotensin receptor blockers and outcomes in patients hospitalized with heart …
LG Gilstrap, GC Fonarow, AS Desai… - Journal of the …, 2017 - Am Heart Assoc
Background Guidelines recommend continuation or initiation of guideline‐directed medical
therapy, including angiotensin‐converting enzyme inhibitors/angiotensin II receptor blockers …
therapy, including angiotensin‐converting enzyme inhibitors/angiotensin II receptor blockers …
Initiation, continuation, or withdrawal of angiotensin-converting enzyme inhibitors/angiotensin receptor blockers and outcomes in patients hospitalized with heart …
LG Gilstrap, GC Fonarow, AS Desai… - Journal of the …, 2017 - scholars.northwestern.edu
Background-Guidelines recommend continuation or initiation of guideline-directed medical
therapy, including angiotensinconverting enzyme inhibitors/angiotensin II receptor blockers …
therapy, including angiotensinconverting enzyme inhibitors/angiotensin II receptor blockers …
Initiation, Continuation, or Withdrawal of Angiotensin‐Converting Enzyme Inhibitors/Angiotensin Receptor Blockers and Outcomes in Patients Hospitalized With Heart …
LG Gilstrap, GC Fonarow, AS Desai, L Liang… - Journal of the American …, 2017 - cir.nii.ac.jp
抄録< jats: sec xml: lang=" en">< jats: title> Background</jats: title>< jats: p xml: lang=" en">
Guidelines recommend continuation or initiation of guideline‐directed medical therapy …
Guidelines recommend continuation or initiation of guideline‐directed medical therapy …
Initiation, Continuation, or Withdrawal of Angiotensin‐Converting Enzyme Inhibitors/Angiotensin Receptor Blockers and Outcomes in Patients Hospitalized With Heart …
LG Gilstrap, GC Fonarow, AS Desai… - Journal of the …, 2017 - dash.harvard.edu
Background: Guidelines recommend continuation or initiation of guideline‐directed medical
therapy, including angiotensin‐converting enzyme inhibitors/angiotensin II receptor blockers …
therapy, including angiotensin‐converting enzyme inhibitors/angiotensin II receptor blockers …
Initiation, Continuation, or Withdrawal of Angiotensin-Converting Enzyme Inhibitors/Angiotensin Receptor Blockers and Outcomes in Patients Hospitalized With Heart …
LG Gilstrap, GC Fonarow, AS Desai… - Journal of the …, 2017 - europepmc.org
Background Guidelines recommend continuation or initiation of guideline‐directed medical
therapy, including angiotensin‐converting enzyme inhibitors/angiotensin II receptor blockers …
therapy, including angiotensin‐converting enzyme inhibitors/angiotensin II receptor blockers …
[PDF][PDF] Initiation, Continuation, or Withdrawal of Angiotensin-Converting Enzyme Inhibitors/Angiotensin Receptor Blockers and Outcomes in Patients Hospitalized With …
LG Gilstrap, GC Fonarow, AS Desai, L Liang… - 2017 - pdfs.semanticscholar.org
Background-—Guidelines recommend continuation or initiation of guideline-directed
medical therapy, including angiotensinconverting enzyme inhibitors/angiotensin II receptor …
medical therapy, including angiotensinconverting enzyme inhibitors/angiotensin II receptor …
[HTML][HTML] Initiation, Continuation, or Withdrawal of Angiotensin‐Converting Enzyme Inhibitors/Angiotensin Receptor Blockers and Outcomes in Patients Hospitalized …
LG Gilstrap, GC Fonarow, AS Desai… - Journal of the …, 2017 - ncbi.nlm.nih.gov
Background Guidelines recommend continuation or initiation of guideline‐directed medical
therapy, including angiotensin‐converting enzyme inhibitors/angiotensin II receptor blockers …
therapy, including angiotensin‐converting enzyme inhibitors/angiotensin II receptor blockers …
Initiation, Continuation, or Withdrawal of Angiotensin-Converting Enzyme Inhibitors/Angiotensin Receptor Blockers and Outcomes in Patients Hospitalized With Heart …
LG Gilstrap, GC Fonarow, AS Desai… - Journal of the …, 2017 - escholarship.org
Guidelines recommend continuation or initiation of guideline-directed medical therapy,
including angiotensin-converting enzyme inhibitors/angiotensin II receptor blockers …
including angiotensin-converting enzyme inhibitors/angiotensin II receptor blockers …
Initiation, Continuation, or Withdrawal of Angiotensin-Converting Enzyme Inhibitors/Angiotensin Receptor Blockers and Outcomes in Patients Hospitalized With Heart …
LG Gilstrap, GC Fonarow, AS Desai… - Journal of the …, 2017 - pubmed.ncbi.nlm.nih.gov
Background Guidelines recommend continuation or initiation of guideline-directed medical
therapy, including angiotensin-converting enzyme inhibitors/angiotensin II receptor blockers …
therapy, including angiotensin-converting enzyme inhibitors/angiotensin II receptor blockers …
Initiation, Continuation, or Withdrawal of Angiotensin-Converting Enzyme Inhibitors/Angiotensin Receptor Blockers and Outcomes in Patients Hospitalized With Heart …
LG Gilstrap, GC Fonarow, AS Desai, L Liang… - 2017 - Am Heart Assoc
Background-—Guidelines recommend continuation or initiation of guideline-directed
medical therapy, including angiotensinconverting enzyme inhibitors/angiotensin II receptor …
medical therapy, including angiotensinconverting enzyme inhibitors/angiotensin II receptor …